Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, describes the Personalized Therapy Management (PTM) platform, enterprise software that aims to address supply chain challenges and support the manufacturing and commercialization of cell and gene therapies. PTM aims to help manufacturers efficiently coordinate and automate chain of custody and chain of identity, ensuring personalized cell and gene therapies reach the right patients at the right time. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.